Log In
Print
BCIQ
Print
Print this Print this
 

Olaptesed pegol (NOX-A12)

  Manage Alerts
Collapse Summary General Information
Company Noxxon Pharma AG
DescriptionChemokine CXC motif ligand 12 (CXCL12; SDF-1) inhibitor developed using Spiegelmer technology
Molecular Target Chemokine CXC motif ligand 12 (CXCL12) (SDF-1)
Mechanism of ActionChemokine CXC motif ligand 12 (CXCL12) (SDF-1) inhibitor
Therapeutic ModalityNucleic acid: Aptamer

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today